Arbutus Biopharma Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arbutus Biopharma Corp
CIK #0001447028
EDGAR Form CIK 2011 - 2026
10-K [0001447028]
10-Q [0001447028]
3 [0001447028]
4 [0001447028]
6-K [0001447028]
8-K [0001447028]
D [0001447028]
SC 13D [0001447028]
SC 13G [0001447028]
Form 13D/13G Filer Form 13D/13G Subject Filed
Two SEAS Capital LP Arbutus Biopharma Corp [2025-08-13]
Morgan Stanley Arbutus Biopharma Corp [2024-06-10]
Whitefort Capital Management LP Arbutus Biopharma Corp [2024-05-09]
Two SEAS Capital LP Arbutus Biopharma Corp [2023-11-21]
Whitefort Capital Management LP Arbutus Biopharma Corp [2023-09-11]
BlackRock Inc Arbutus Biopharma Corp [2023-02-03]
Morgan Stanley Arbutus Biopharma Corp [2020-07-16]
Foresite Capital Fund IV LP Arbutus Biopharma Corp [2019-12-09]
PRIMECAP Management Co/CA/ Arbutus Biopharma Corp [2019-11-05]
EcoR1 Capital LLC Arbutus Biopharma Corp [2019-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Beardsley Robert A
Arbutus Biopharma Corp
Sawhney Roger
Nguyen Tuan
Androski Lindsay
Hasija Anuj
Bishop Joseph E
Gline Matthew
Naftzger J Christopher
Sims Karen
Hastings David C
McElhaugh Michael J
Manchester Keith S
Meyers James R
Rewolinski Melissa
Burgess Daniel D
Henriques Richard C Jr
Torti Frank
Sofia Michael J
Collier William H
Howard Elizabeth
Tran Tram
Picchio Gaston
Roivant Sciences Ltd
Cheng Andrew
Venker Eric
Potter Myrtle S
Lo Andrew
Machado Patrick
QVT Fund V LP
QVT Associates GP LLC
Oren Dan
Dexcel Pharma Technologies Ltd
Dexxon Holdings Ltd
Viking Global Equities LP
Viking Global Equities II LP
Viking Long Fund Master Ltd
VGE III Portfolio Ltd
Viking Global Performance LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Viking Long Fund GP LLC
Viking Global Equities Master Ltd
Ott David C
SVF Investments UK Ltd
SVF Holdings UK LLP
SoftBank Vision Fund LP
SVF GP Jersey Ltd
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Portfolio GP LLC
Murray Mark J
VandenEnden Koert
Conrad Herbert J
Ramaswamy Vivek
Symonds William T
Lutwyche Peter
Cousins Bruce
Karbe Frank
Abrams Michael J
Kowalski Mark
Sundheim Daniel S
Higgins Patrick T
Jewell Donald Gordon
Phillips Peggy V
Gardiner Diane
Brennan Paul A
Kisner Daniel L
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 71,700 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2026-02-02 Grant 73,500 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 188,400 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2026-02-02 Grant 28,000 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-08-04 Grant 157,600 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-03-31 Grant 750,000 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-03-18 Grant 310,422 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-03-18 Grant 157,600 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-03-18 Grant 157,600 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-02-14 Grant 200,300 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-14 Grant 54,300 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-14 Grant 177,000 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-14 Grant 90,100 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-14 Grant 49,300 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-02-14 Grant 220,300 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-02-14 Grant 718,800 $0.00
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
2025-02-14 Grant 365,800 $0.00
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-04 Sell 22,183 $3.28 72,760
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-04 Sell 11,333 $3.28 37,172
Arbutus Biopharma Corp ABUS
Common Shares
2025-02-04 Sell 23,790 $3.28 78,031
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com